Overview of Immunotherapy in Cancer

Contact Hours: 2.0

ACPE UAN: 0384-9999-19-113-H04-T

 The National Pharmacy Technician Association (NPTA) is accredited by the Accreditation Council for
 Pharmacy Education (ACPE) as a provider of continuing pharmacy education.

Target Audience: Certified Pharmacy Technicians

This CPE activity has been designated as a knowledge-based program.

Author: Thao K. Huynh PharmD BCOP

Faculty Disclosures/Conflicts of Interest: Author declared no conflict of interest and all information is provided fairly and without bias. Author received no commercial/financial support for this activity and do not approve or endorse any commercial products displayed.

Goals & Objectives:

At the completion of this activity, participants should be able to:

• List the different types of immunotherapy and its therapeutic agents.
• Describe the mechanism of immune checkpoint inhibitors.
• Discuss the administration of chimeric antigen receptor (CAR) T-cell therapy.
• Describe the adverse events of high dose interleukin 2 therapy and discharge patient counseling.
• List the major advantage and disadvantage of sipuleucel-T therapy.
• Describe the administration of talimogene laherparepvec therapy.
• Discuss the future of immunotherapy. 

Release Date: 09/13/2019

Expiration Date: 09/13/2022